Using two pre-validated shRNA sequences, we were not able to obtain stable clones with silenced MEIS2 after selection with puromycin, suggesting that basal/sustained expression level of MEIS2 is determinant for MM survival. Here, MEIS2 is linked to Miyoshi myopathy.